Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Proteomic analysis of human thyroid cell lines reveals reduced nuclear localization of Mn-SOD in poorly differentiated thyroid cancer cells.

Russo D, Bisca A, Celano M, Talamo F, Arturi F, Scipioni A, Presta I, Bulotta S, Ferretti E, Filetti S, Scaloni A, Damante G, Tell G.

J Endocrinol Invest. 2005 Feb;28(2):137-44.

PMID:
15887859
2.

Manganese superoxide dismutase content and localization in human thyroid tumours.

Nishida S, Akai F, Iwasaki H, Hosokawa K, Kusunoki T, Suzuki K, Taniguchi N, Hashimoto S, Tamura TT.

J Pathol. 1993 Mar;169(3):341-5.

PMID:
8492227
3.

Localization of Cu/Zn and Mn superoxide dismutase in various thyroid disorders.

Iwase K, Nagasaka A, Kato K, Ohtani S, Tsujimura T, Inagaki A, Jimbo S, Nakai A, Masunaga R, Hamada M, et al.

Acta Endocrinol (Copenh). 1993 Dec;129(6):573-8.

PMID:
7509102
4.

Telomerase activity in human thyroid carcinomas originating from the follicular cells.

Brousset P, Chaouche N, Leprat F, Branet-Brousset F, Trouette H, Zenou RC, Merlio JP, Delsol G.

J Clin Endocrinol Metab. 1997 Dec;82(12):4214-6.

PMID:
9398742
5.

[Study of the localization and the concentration of superoxide dismutase in various thyroid disorders].

Iwase K, Kato K, Otani S, Tsujimura T, Inagaki A, Miura K.

Nihon Geka Gakkai Zasshi. 1993 Oct;94(10):1112-7. Japanese.

PMID:
8232185
6.

Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues.

Weyemi U, Caillou B, Talbot M, Ameziane-El-Hassani R, Lacroix L, Lagent-Chevallier O, Al Ghuzlan A, Roos D, Bidart JM, Virion A, Schlumberger M, Dupuy C.

Endocr Relat Cancer. 2010 Jan 29;17(1):27-37. doi: 10.1677/ERC-09-0175. Print 2010 Mar.

7.
8.

Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers.

Arcolia V, Paci P, Dhont L, Chantrain G, Sirtaine N, Decaestecker C, Remmelink M, Belayew A, Saussez S.

BMC Cancer. 2014 Jul 8;14:492. doi: 10.1186/1471-2407-14-492.

9.

Mutation of the PIK3CA gene in anaplastic thyroid cancer.

García-Rostán G, Costa AM, Pereira-Castro I, Salvatore G, Hernandez R, Hermsem MJ, Herrero A, Fusco A, Cameselle-Teijeiro J, Santoro M.

Cancer Res. 2005 Nov 15;65(22):10199-207.

10.

High-level expression, activation, and subcellular localization of p38-MAP kinase in thyroid neoplasms.

Pomérance M, Quillard J, Chantoux F, Young J, Blondeau JP.

J Pathol. 2006 Jul;209(3):298-306.

PMID:
16583356
11.

Raf-1 kinase inhibitory protein expression in thyroid carcinomas.

Kim HS, Kim GY, Lim SJ, Kim YW.

Endocr Pathol. 2010 Dec;21(4):253-7. doi: 10.1007/s12022-010-9131-x.

PMID:
20734161
12.

CD10 expression is useful in the diagnosis of follicular carcinoma and follicular variant of papillary thyroid carcinoma.

Tomoda C, Kushima R, Takeuti E, Mukaisho K, Hattori T, Kitano H.

Thyroid. 2003 Mar;13(3):291-5.

PMID:
12729479
13.

Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.

Chernock RD, El-Mofty SK, Becker N, Lewis JS Jr.

Am J Surg Pathol. 2013 Aug;37(8):1215-22. doi: 10.1097/PAS.0b013e318283b7b2.

PMID:
23681073
14.

ApeI/Ref-I expression and cellular localization in human thyroid carcinoma cell lines.

Russo D, Arturi F, Bulotta S, Pellizzari L, Filetti S, Manzini G, Damante G, Tell G.

J Endocrinol Invest. 2001 Mar;24(3):RC10-2.

PMID:
11314755
15.

Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.

Motti ML, Califano D, Baldassarre G, Celetti A, Merolla F, Forzati F, Napolitano M, Tavernise B, Fusco A, Viglietto G.

Carcinogenesis. 2005 Jun;26(6):1021-34. Epub 2005 Feb 17.

PMID:
15718252
16.

Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues.

Ulisse S, Delcros JG, Baldini E, Toller M, Curcio F, Giacomelli L, Prigent C, Ambesi-Impiombato FS, D'Armiento M, Arlot-Bonnemains Y.

Int J Cancer. 2006 Jul 15;119(2):275-82.

17.

The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers.

Pannone G, Santoro A, Pasquali D, Zamparese R, Mattoni M, Russo G, Landriscina M, Piscazzi A, Toti P, Cignarelli M, Lo Muzio L, Bufo P.

Thyroid. 2014 Mar;24(3):511-9. doi: 10.1089/thy.2013.0196. Epub 2013 Dec 13.

PMID:
24117205
18.

Expression of telomerase genes in thyroid carcinoma.

Hoang-Vu C, Boltze C, Gimm O, Poremba C, Dockhorn-Dworniczak B, Köhrle J, Rath FW, Dralle H.

Int J Oncol. 2002 Aug;21(2):265-72. Review.

PMID:
12118320
19.

Expression of alpha1,6-fucosyltransferase (FUT8) in papillary carcinoma of the thyroid: its linkage to biological aggressiveness and anaplastic transformation.

Ito Y, Miyauchi A, Yoshida H, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Taniguchi N, Matsuura N, Kuma K, Miyoshi E.

Cancer Lett. 2003 Oct 28;200(2):167-72.

PMID:
14568171
20.

Decreased expression of catalase mRNA in thyroid anaplastic carcinoma.

Hasegawa Y, Takano T, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, Amino N.

Jpn J Clin Oncol. 2003 Jan;33(1):6-9.

PMID:
12604716

Supplemental Content

Support Center